VL
Eolo Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| MVD-1 (SANA) | Obesity | Phase 1 |
| Eolo40 NCE | ALS | Discovery |
| NF-kB inhibitor | Alzheimer's Disease | Discovery |
| Drug | Indication | Phase |
|---|---|---|
| MVD-1 (SANA) | Obesity | Phase 1 |
| Eolo40 NCE | ALS | Discovery |
| NF-kB inhibitor | Alzheimer's Disease | Discovery |